TGTX
Tg Therapeutics Inc Earnings
$28.57
Earnings Summary
Revenue | $141.15Mn |
Net Profits | $28.19Mn |
Net Profit Margins | 19.97% |
Tg Therapeutics Inc’s revenue jumped 92.13% since last year same period to $141.15Mn in the Q2 2025. On a quarterly growth basis, Tg Therapeutics Inc has generated 16.79% jump in its revenue since last 3-months.
Tg Therapeutics Inc’s net profit jumped 309.75% since last year same period to $28.19Mn in the Q2 2025. On a quarterly growth basis, Tg Therapeutics Inc has generated 457.06% jump in its net profits since last 3-months.
Tg Therapeutics Inc’s net profit margin jumped 113.27% since last year same period to 19.97% in the Q2 2025. On a quarterly growth basis, Tg Therapeutics Inc has generated 376.97% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | 0.25 |
EPS Estimate Current Year | 0.25 |
Tg Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at 0.25 - a 33.79% jump from last quarter’s estimates.
Tg Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at 0.25.
Key Ratios
Earning Per Share (EPS) | 0 |
Tg Therapeutics Inc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Tg Therapeutics Inc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-06-30 | 0.19 | 0.17 | -10.53% |
2025-05-09 | 0.17 | 0.03 | -82.76% |
2025-10-30 | 0.25 | 0 | -100% |
